Merriman Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CIP
JSP
BCM
Merriman Wealth Management's TNDM Position: Q1 2022 in Review
Merriman Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 1,500 shares — an estimated $226K sold.
Merriman Wealth Management first reported a position in TNDM in Q3 2020 and held it in 2 quarters. The position peaked at $227K in Q3 2020. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.
- Merriman Wealth Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
- Merriman Wealth Management sold 1,500 Tandem Diabetes Care shares in Q1 2022, an estimated $226K.
- Merriman Wealth Management first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 2 quarters.
- Merriman Wealth Management's Tandem Diabetes Care position peaked at $227K in Q3 2020.
- 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.
Based on Merriman Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.